Citation Impact
Citing Papers
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
PET in oncology: Will it replace the other modalities?
1997
FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CT
1998
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Données actuelles et perspectives de la tomographie par émission de positrons en oncologie-radiothérapie
1999
Selective use of PET scan in the preoperative staging of NSCLC
1998
PET and [18F]-FDG in oncology: A clinical update
1996
Cushing's syndrome
2015 Standout
Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction
1999
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
1993
Likelihood of Malignancy in a Solitary Pulmonary Nodule
1997
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Conformity index: A review
2006 Standout
Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications
1997
Germ Cell Tumor: Differentiation of Viable Tumor, Mature Teratoma, and Necrotic Tissue with FDG PET and Kinetic Modeling
1999
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
1996
Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging
1995
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Radiology of colorectal cancer
2002
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
1999 Standout
Clinical imaging of cancer metastasis
2000
The Role of Whole-Body Positron Emission Tomography With [18F]Fluorodeoxyglucose in Identifying Operable Colorectal Cancer Metastases to the Liver
1996
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Iodine-124: A Promising Positron Emitter for Organic PET Chemistry
2010
Noninvasive grading of musculoskeletal tumors using PET.
1991
Unconventional nuclides for radiopharmaceuticals.
2010
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer
1994
Unconventional Nuclides for Radiopharmaceuticals
2010
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Resection of colorectal liver metastases
1995 Standout
Works of F. Helus being referenced
Recurrence of colorectal tumors: PET evaluation.
1989
Experiences in the routine production of123I via the124Te(p, 2n)123I reaction with a low energy cyclotron
1981
Experiences in the routine-production of 123I via the 124Te(p, 2n) 123I reaction with a low energy cyclotron
1982
Production of75Br and77Br from enriched krypton: Excitation functions
1991
Routine production of38K for medical use
1980
Production of 34m Cl from a gaseous hydrogen sulfide target
1984